Aurinia Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA05156V1022

SecurityAUPH / Aurinia Pharmaceuticals Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership385,856 shares
Latest Disclosed Value $ 5,718,386
UBS Group AG ownership in AUPH / Aurinia Pharmaceuticals Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 385,856 shares of Aurinia Pharmaceuticals Inc. (US:AUPH) valued at $5,718,386 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 254,672 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of 51.51% during the quarter. The current value of the position is $6,316,463 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (AUPH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AUPH / Aurinia Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 385,856 131,184 51.51 5,718 40.77 0.0009
2026-01-29 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 254,672 55,924 28.14 4,062 84.97 0.0007
2025-11-13 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 198,748 -126,881 -38.96 2,196 -20.38 0.0003
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 325,629 68,490 26.64 2,758 33.43 0.0005
2025-05-13 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 257,139 43,866 20.57 2,067 7.94 0.0004
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 213,273 62,574 41.52 1,915 73.46 0.0004
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 150,699 13,525 9.86 1,105 41.00 0.0002
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 137,174 -63,608 -31.68 783 -22.09 0.0002
2024-05-13 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 200,782 -52,706 -20.79 1,006 -55.88 0.0003
2024-02-09 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 253,488 61,306 31.90 2,279 52.58 0.0007
2023-11-09 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 192,182 -50,188 -20.71 1,493 -36.36 0.0005
2023-08-11 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 242,370 110,901 84.36 2,346 62.92 0.0008
2023-05-12 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 131,469 84,912 182.38 1,441 616.42 0.0005
2023-02-08 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 46,557 9,832 26.77 201 -27.17 0.0001
2022-11-10 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 36,725 -113,293 -75.52 276 -81.70 0.0001
2022-08-10 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 150,018 -25,549 -14.55 1,508 -30.63 0.0006
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 175,567 61,781 54.30 2,174 -16.45 0.0007
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 113,786 -123,943 -52.14 2,602 -50.54 0.0007
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 237,729 -22,476 -8.64 5,261 56.02 0.0017
2021-08-13 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 260,205 5,373 2.11 3,372 1.90 0.0011
2021-05-12 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 254,832 38,749 17.93 3,309 10.74 0.0011
2021-02-11 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 216,083 46,767 27.62 2,988 19.81 0.0010
2020-11-12 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 169,316 67,534 66.35 2,494 50.79 0.0009
2020-07-31 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 101,782 -20,620 -16.85 1,654 -6.87 0.0007
2020-05-01 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 122,402 39,442 47.54 1,776 5.65 0.0008
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 82,960 75,906 1,076.07 1,681 4,323.68 0.0006
2019-11-14 2019-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 7,054 611 9.48 38 -9.52 0.0000
2019-08-14 2019-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 6,443 -581 -8.27 42 -8.70 0.0000
2019-05-14 2019-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 7,024 -1,158 -14.15 46 -16.36 0.0000
2019-02-14 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 8,182 -120,788 -93.66 55 -93.58 0.0000
2018-11-14 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 128,970 8,535 7.09 857 26.40 0.0003
2018-08-14 2018-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 120,435 5,000 4.33 678 13.19 0.0003
2018-05-15 2018-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 115,435 -3,400 -2.86 599 11.34 0.0003
2018-02-14 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 118,835 26,000 28.01 538 -7.56 0.0002
2017-11-14 2017-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 92,835 -5,705 -5.79 582 -3.64 0.0003
2017-11-14 2017-06-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 98,540 -13,774 -12.26 604 -26.70 0.0003
2017-08-14 2017-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 98,540 -13,774 604
2017-11-14 2017-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 112,314 13,405 13.55 824 296.15 0.0004
2017-05-12 2017-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 112,314 13,405 824
2017-02-14 2016-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 98,909 29,549 42.60 208 -0.48 0.0001
2016-11-14 2016-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 69,360 69,360 0.00 209 0.0001
2016-08-12 2016-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -2,019 -100.00 0 -100.00
2016-05-12 2016-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,019 -14,891 -88.06 6 -85.71 0.0000
2016-02-16 2015-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 16,910 16,910 42 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-08-10 2022-06-30 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM Call 29,600 366 n/a n/a n/a
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS COM Call 15,400 341 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F AURINIA PHARMACEUTICALS COM Put 10,000 221 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.